These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 33441146

  • 41. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Buhl R, Magder S, Bothner U, Tetzlaff K, Voß F, Loaiza L, Vogelmeier CF, McGarvey L.
    Respir Med; 2017 Jan; 122():58-66. PubMed ID: 27993292
    [Abstract] [Full Text] [Related]

  • 42. Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study.
    Greulich T, Kostikas K, Gaga M, Aalamian-Mattheis M, Lossi NS, Patalano F, Nunez X, Pagano VA, Fogel R, Vogelmeier CF, Clemens A.
    Int J Chron Obstruct Pulmon Dis; 2018 Jan; 13():1229-1237. PubMed ID: 29713156
    [Abstract] [Full Text] [Related]

  • 43. Long-acting muscarinic antagonist and long-acting β2-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review.
    Buhl R, Miravitlles M, Anzueto A, Brunton S.
    Ther Adv Respir Dis; 2024 Jan; 18():17534666241279115. PubMed ID: 39352722
    [Abstract] [Full Text] [Related]

  • 44. A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol.
    Buhl R, Dreher M, Korn S, Taube C, Stock C, Zehendner CM, Kondla A, Vogelmeier CF.
    Int J Chron Obstruct Pulmon Dis; 2020 Jan; 15():2601-2608. PubMed ID: 33122898
    [Abstract] [Full Text] [Related]

  • 45. Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics.
    Jabbal S, Kuo CR, Lipworth B.
    Clin Exp Allergy; 2020 Oct; 50(10):1140-1147. PubMed ID: 33180376
    [Abstract] [Full Text] [Related]

  • 46. Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study.
    Kawachi S, Fujimoto K.
    Int J Chron Obstruct Pulmon Dis; 2019 Oct; 14():1167-1176. PubMed ID: 31213796
    [Abstract] [Full Text] [Related]

  • 47. The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects.
    Derom E, Brusselle GG, Joos GF.
    Ther Adv Respir Dis; 2019 Oct; 13():1753466619843426. PubMed ID: 31002020
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis.
    Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct; 12():3469-3485. PubMed ID: 29255354
    [Abstract] [Full Text] [Related]

  • 50. Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment.
    Cheng SL.
    J Clin Med; 2021 Jun 16; 10(12):. PubMed ID: 34208599
    [Abstract] [Full Text] [Related]

  • 51. Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD.
    Chan MC, Tan EC, Yang MC.
    Int J Chron Obstruct Pulmon Dis; 2018 Jun 16; 13():1079-1088. PubMed ID: 29670344
    [Abstract] [Full Text] [Related]

  • 52. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA, Cates CJ.
    Cochrane Database Syst Rev; 2015 Oct 22; (10):CD008989. PubMed ID: 26490945
    [Abstract] [Full Text] [Related]

  • 53. Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
    Hahn B, Hull M, Blauer-Peterson C, Buikema AR, Ray R, Stanford RH.
    Respir Med; 2018 Jun 22; 139():65-71. PubMed ID: 29858004
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
    Aalbers R, Maleki-Yazdi MR, Hamilton A, Waitere-Wijker S, Zhao Y, Amatto VC, Schmidt O, Bjermer L.
    Adv Ther; 2015 Sep 22; 32(9):809-22. PubMed ID: 26404912
    [Abstract] [Full Text] [Related]

  • 56. LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data.
    Gong Y, Sui Z, Lv Y, Zheng Q, Li L.
    Eur J Clin Pharmacol; 2023 Oct 22; 79(10):1321-1332. PubMed ID: 37507595
    [Abstract] [Full Text] [Related]

  • 57. Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non-frequently exacerbating COPD patients: The FLASH randomized controlled trial.
    Frith PA, Ashmawi S, Krishnamurthy S, Gurgun A, Hristoskova S, Pilipovic V, Hamann AM, Backer A, Olsson P, Kostikas K, Diaz DV, FLASH Investigators.
    Respirology; 2018 Dec 22; 23(12):1152-1159. PubMed ID: 30074294
    [Abstract] [Full Text] [Related]

  • 58. New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives.
    Singh D.
    Br J Clin Pharmacol; 2015 May 22; 79(5):695-708. PubMed ID: 25377687
    [Abstract] [Full Text] [Related]

  • 59. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
    Kardos P, Worsley S, Singh D, Román-Rodríguez M, Newby DE, Müllerová H.
    Int J Chron Obstruct Pulmon Dis; 2016 May 22; 11():2885-2895. PubMed ID: 27932872
    [Abstract] [Full Text] [Related]

  • 60. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
    Feldman GJ, Edin A.
    Ther Adv Respir Dis; 2013 Dec 22; 7(6):311-9. PubMed ID: 24004659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.